Global Onychomycosis (Tinea Unguium) Drug Market Growth 2021-2026
The report requires updating with new data and is sent in 48 hours after order is placed.
According to this latest study, the 2021 growth of Onychomycosis (Tinea Unguium) Drug will have significant change from previous year. By the most conservative estimates of global Onychomycosis (Tinea Unguium) Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 2988.7 million in 2020. Over the next five years the Onychomycosis (Tinea Unguium) Drug market will register a 3.2% CAGR in terms of revenue, the global market size will reach US$ 3392.1 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Onychomycosis (Tinea Unguium) Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
According to this latest study, the 2021 growth of Onychomycosis (Tinea Unguium) Drug will have significant change from previous year. By the most conservative estimates of global Onychomycosis (Tinea Unguium) Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 2988.7 million in 2020. Over the next five years the Onychomycosis (Tinea Unguium) Drug market will register a 3.2% CAGR in terms of revenue, the global market size will reach US$ 3392.1 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Onychomycosis (Tinea Unguium) Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
- Oral Medication
- External Medicine
- Age under 18
- Age 18-50
- Age above 50
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Johnson and Johnson
- GSK
- Novartis
- Pfizer
- Valeant Pharma
- Kaken Pharmaceutical
- Galderma
- Xiuzheng Pharmaceutical
- Letai
- Qilu Pharmaceutical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Onychomycosis (Tinea Unguium) Drug Consumption 2016-2026
2.1.2 Onychomycosis (Tinea Unguium) Drug Consumption CAGR by Region
2.2 Onychomycosis (Tinea Unguium) Drug Segment by Type
2.2.1 Oral Medication
2.2.2 External Medicine
2.3 Onychomycosis (Tinea Unguium) Drug Sales by Type
2.3.1 Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2016-2021)
2.3.2 Global Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Type (2016-2021)
2.3.3 Global Onychomycosis (Tinea Unguium) Drug Sale Price by Type (2016-2021)
2.4 Onychomycosis (Tinea Unguium) Drug Segment by Application
2.4.1 Age under
2.4.2 Age 18-50
2.4.3 Age above
2.5 Onychomycosis (Tinea Unguium) Drug Sales by Application
2.5.1 Global Onychomycosis (Tinea Unguium) Drug Sale Market Share by Application (2016-2021)
2.5.2 Global Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Application (2016-2021)
2.5.3 Global Onychomycosis (Tinea Unguium) Drug Sale Price by Application (2016-2021)
3 GLOBAL ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG BY COMPANY
3.1 Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Company
3.1.1 Global Onychomycosis (Tinea Unguium) Drug Sales by Company (2019-2021)
3.1.2 Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Company (2019-2021)
3.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Company
3.2.1 Global Onychomycosis (Tinea Unguium) Drug Revenue by Company (2019-2021)
3.2.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Company (2019-2021)
3.3 Global Onychomycosis (Tinea Unguium) Drug Sale Price by Company
3.4 Global Manufacturers Onychomycosis (Tinea Unguium) Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Onychomycosis (Tinea Unguium) Drug Product Location Distribution
3.4.2 Players Onychomycosis (Tinea Unguium) Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG BY REGION
4.1 Global Onychomycosis (Tinea Unguium) Drug by Region
4.1.1 Global Onychomycosis (Tinea Unguium) Drug Sales by Region
4.1.2 Global Onychomycosis (Tinea Unguium) Drug Revenue by Region
4.2 Americas Onychomycosis (Tinea Unguium) Drug Sales Growth
4.3 APAC Onychomycosis (Tinea Unguium) Drug Sales Growth
4.4 Europe Onychomycosis (Tinea Unguium) Drug Sales Growth
4.5 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales Growth
5 AMERICAS
5.1 Americas Onychomycosis (Tinea Unguium) Drug Sales by Country
5.1.1 Americas Onychomycosis (Tinea Unguium) Drug Sales by Country (2016-2021)
5.1.2 Americas Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2021)
5.2 Americas Onychomycosis (Tinea Unguium) Drug Sales by Type
5.3 Americas Onychomycosis (Tinea Unguium) Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Onychomycosis (Tinea Unguium) Drug Sales by Region
6.1.1 APAC Onychomycosis (Tinea Unguium) Drug Sales by Region (2016-2021)
6.1.2 APAC Onychomycosis (Tinea Unguium) Drug Revenue by Region (2016-2021)
6.2 APAC Onychomycosis (Tinea Unguium) Drug Sales by Type
6.3 APAC Onychomycosis (Tinea Unguium) Drug Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Onychomycosis (Tinea Unguium) Drug by Country
7.1.1 Europe Onychomycosis (Tinea Unguium) Drug Sales by Country (2016-2021)
7.1.2 Europe Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2021)
7.2 Europe Onychomycosis (Tinea Unguium) Drug Sales by Type
7.3 Europe Onychomycosis (Tinea Unguium) Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Onychomycosis (Tinea Unguium) Drug by Country
8.1.1 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales by Country (2016-2021)
8.1.2 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2021)
8.2 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales by Type
8.3 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Onychomycosis (Tinea Unguium) Drug Distributors
10.3 Onychomycosis (Tinea Unguium) Drug Customer
11 GLOBAL ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET FORECAST
11.1 Global Onychomycosis (Tinea Unguium) Drug Forecast by Region
11.1.1 Global Onychomycosis (Tinea Unguium) Drug Forecast by Regions (2021-2026)
11.2.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Onychomycosis (Tinea Unguium) Drug Forecast by Type
11.7 Global Onychomycosis (Tinea Unguium) Drug Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 Johnson and Johnson
12.1.1 Johnson and Johnson Company Information
12.1.2 Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Product Offered
12.1.3 Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Johnson and Johnson Main Business Overview
12.1.5 Johnson and Johnson Latest Developments
12.2 GSK
12.2.1 GSK Company Information
12.2.2 GSK Onychomycosis (Tinea Unguium) Drug Product Offered
12.2.3 GSK Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 GSK Main Business Overview
12.2.5 GSK Latest Developments
12.3 Novartis
12.3.1 Novartis Company Information
12.3.2 Novartis Onychomycosis (Tinea Unguium) Drug Product Offered
12.3.3 Novartis Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Novartis Main Business Overview
12.3.5 Novartis Latest Developments
12.4 Pfizer
12.4.1 Pfizer Company Information
12.4.2 Pfizer Onychomycosis (Tinea Unguium) Drug Product Offered
12.4.3 Pfizer Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Pfizer Main Business Overview
12.4.5 Pfizer Latest Developments
12.5 Valeant Pharma
12.5.1 Valeant Pharma Company Information
12.5.2 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product Offered
12.5.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Valeant Pharma Main Business Overview
12.5.5 Valeant Pharma Latest Developments
12.6 Kaken Pharmaceutical
12.6.1 Kaken Pharmaceutical Company Information
12.6.2 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Offered
12.6.3 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Kaken Pharmaceutical Main Business Overview
12.6.5 Kaken Pharmaceutical Latest Developments
12.7 Galderma
12.7.1 Galderma Company Information
12.7.2 Galderma Onychomycosis (Tinea Unguium) Drug Product Offered
12.7.3 Galderma Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Galderma Main Business Overview
12.7.5 Galderma Latest Developments
12.8 Xiuzheng Pharmaceutical
12.8.1 Xiuzheng Pharmaceutical Company Information
12.8.2 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Offered
12.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Xiuzheng Pharmaceutical Main Business Overview
12.8.5 Xiuzheng Pharmaceutical Latest Developments
12.9 Letai
12.9.1 Letai Company Information
12.9.2 Letai Onychomycosis (Tinea Unguium) Drug Product Offered
12.9.3 Letai Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Letai Main Business Overview
12.9.5 Letai Latest Developments
12.10 Qilu Pharmaceutical
12.10.1 Qilu Pharmaceutical Company Information
12.10.2 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Offered
12.10.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Qilu Pharmaceutical Main Business Overview
12.10.5 Qilu Pharmaceutical Latest Developments
13 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Onychomycosis (Tinea Unguium) Drug Consumption 2016-2026
2.1.2 Onychomycosis (Tinea Unguium) Drug Consumption CAGR by Region
2.2 Onychomycosis (Tinea Unguium) Drug Segment by Type
2.2.1 Oral Medication
2.2.2 External Medicine
2.3 Onychomycosis (Tinea Unguium) Drug Sales by Type
2.3.1 Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2016-2021)
2.3.2 Global Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Type (2016-2021)
2.3.3 Global Onychomycosis (Tinea Unguium) Drug Sale Price by Type (2016-2021)
2.4 Onychomycosis (Tinea Unguium) Drug Segment by Application
2.4.1 Age under
2.4.2 Age 18-50
2.4.3 Age above
2.5 Onychomycosis (Tinea Unguium) Drug Sales by Application
2.5.1 Global Onychomycosis (Tinea Unguium) Drug Sale Market Share by Application (2016-2021)
2.5.2 Global Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Application (2016-2021)
2.5.3 Global Onychomycosis (Tinea Unguium) Drug Sale Price by Application (2016-2021)
3 GLOBAL ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG BY COMPANY
3.1 Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Company
3.1.1 Global Onychomycosis (Tinea Unguium) Drug Sales by Company (2019-2021)
3.1.2 Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Company (2019-2021)
3.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Company
3.2.1 Global Onychomycosis (Tinea Unguium) Drug Revenue by Company (2019-2021)
3.2.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Company (2019-2021)
3.3 Global Onychomycosis (Tinea Unguium) Drug Sale Price by Company
3.4 Global Manufacturers Onychomycosis (Tinea Unguium) Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Onychomycosis (Tinea Unguium) Drug Product Location Distribution
3.4.2 Players Onychomycosis (Tinea Unguium) Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG BY REGION
4.1 Global Onychomycosis (Tinea Unguium) Drug by Region
4.1.1 Global Onychomycosis (Tinea Unguium) Drug Sales by Region
4.1.2 Global Onychomycosis (Tinea Unguium) Drug Revenue by Region
4.2 Americas Onychomycosis (Tinea Unguium) Drug Sales Growth
4.3 APAC Onychomycosis (Tinea Unguium) Drug Sales Growth
4.4 Europe Onychomycosis (Tinea Unguium) Drug Sales Growth
4.5 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales Growth
5 AMERICAS
5.1 Americas Onychomycosis (Tinea Unguium) Drug Sales by Country
5.1.1 Americas Onychomycosis (Tinea Unguium) Drug Sales by Country (2016-2021)
5.1.2 Americas Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2021)
5.2 Americas Onychomycosis (Tinea Unguium) Drug Sales by Type
5.3 Americas Onychomycosis (Tinea Unguium) Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Onychomycosis (Tinea Unguium) Drug Sales by Region
6.1.1 APAC Onychomycosis (Tinea Unguium) Drug Sales by Region (2016-2021)
6.1.2 APAC Onychomycosis (Tinea Unguium) Drug Revenue by Region (2016-2021)
6.2 APAC Onychomycosis (Tinea Unguium) Drug Sales by Type
6.3 APAC Onychomycosis (Tinea Unguium) Drug Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Onychomycosis (Tinea Unguium) Drug by Country
7.1.1 Europe Onychomycosis (Tinea Unguium) Drug Sales by Country (2016-2021)
7.1.2 Europe Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2021)
7.2 Europe Onychomycosis (Tinea Unguium) Drug Sales by Type
7.3 Europe Onychomycosis (Tinea Unguium) Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Onychomycosis (Tinea Unguium) Drug by Country
8.1.1 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales by Country (2016-2021)
8.1.2 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2021)
8.2 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales by Type
8.3 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Onychomycosis (Tinea Unguium) Drug Distributors
10.3 Onychomycosis (Tinea Unguium) Drug Customer
11 GLOBAL ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET FORECAST
11.1 Global Onychomycosis (Tinea Unguium) Drug Forecast by Region
11.1.1 Global Onychomycosis (Tinea Unguium) Drug Forecast by Regions (2021-2026)
11.2.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Onychomycosis (Tinea Unguium) Drug Forecast by Type
11.7 Global Onychomycosis (Tinea Unguium) Drug Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 Johnson and Johnson
12.1.1 Johnson and Johnson Company Information
12.1.2 Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Product Offered
12.1.3 Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Johnson and Johnson Main Business Overview
12.1.5 Johnson and Johnson Latest Developments
12.2 GSK
12.2.1 GSK Company Information
12.2.2 GSK Onychomycosis (Tinea Unguium) Drug Product Offered
12.2.3 GSK Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 GSK Main Business Overview
12.2.5 GSK Latest Developments
12.3 Novartis
12.3.1 Novartis Company Information
12.3.2 Novartis Onychomycosis (Tinea Unguium) Drug Product Offered
12.3.3 Novartis Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Novartis Main Business Overview
12.3.5 Novartis Latest Developments
12.4 Pfizer
12.4.1 Pfizer Company Information
12.4.2 Pfizer Onychomycosis (Tinea Unguium) Drug Product Offered
12.4.3 Pfizer Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Pfizer Main Business Overview
12.4.5 Pfizer Latest Developments
12.5 Valeant Pharma
12.5.1 Valeant Pharma Company Information
12.5.2 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product Offered
12.5.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Valeant Pharma Main Business Overview
12.5.5 Valeant Pharma Latest Developments
12.6 Kaken Pharmaceutical
12.6.1 Kaken Pharmaceutical Company Information
12.6.2 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Offered
12.6.3 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Kaken Pharmaceutical Main Business Overview
12.6.5 Kaken Pharmaceutical Latest Developments
12.7 Galderma
12.7.1 Galderma Company Information
12.7.2 Galderma Onychomycosis (Tinea Unguium) Drug Product Offered
12.7.3 Galderma Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Galderma Main Business Overview
12.7.5 Galderma Latest Developments
12.8 Xiuzheng Pharmaceutical
12.8.1 Xiuzheng Pharmaceutical Company Information
12.8.2 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Offered
12.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Xiuzheng Pharmaceutical Main Business Overview
12.8.5 Xiuzheng Pharmaceutical Latest Developments
12.9 Letai
12.9.1 Letai Company Information
12.9.2 Letai Onychomycosis (Tinea Unguium) Drug Product Offered
12.9.3 Letai Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Letai Main Business Overview
12.9.5 Letai Latest Developments
12.10 Qilu Pharmaceutical
12.10.1 Qilu Pharmaceutical Company Information
12.10.2 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Offered
12.10.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Qilu Pharmaceutical Main Business Overview
12.10.5 Qilu Pharmaceutical Latest Developments
13 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Onychomycosis (Tinea Unguium) Drug Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Oral Medication
Table 3. Major Players of External Medicine
Table 4. Global Onychomycosis (Tinea Unguium) Drug Sales by Type (2016-2021) & (K Units)
Table 5. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2016-2021)
Table 6. Global Onychomycosis (Tinea Unguium) Drug Revenue by Type (2016-2021) & ($ million)
Table 7. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Type (2016-2021)
Table 8. Global Onychomycosis (Tinea Unguium) Drug Sale Price by Type (2016-2021)
Table 9. Global Onychomycosis (Tinea Unguium) Drug Sales by Application (2016-2021) & (K Units)
Table 10. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2016-2021)
Table 11. Global Onychomycosis (Tinea Unguium) Drug Value by Application (2016-2021)
Table 12. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Application (2016-2021)
Table 13. Global Onychomycosis (Tinea Unguium) Drug Sale Price by Application (2016-2021)
Table 14. Global Onychomycosis (Tinea Unguium) Drug Sales by Company (2019-2021) & (K Units)
Table 15. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Company (2019-2021)
Table 16. Global Onychomycosis (Tinea Unguium) Drug Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Company (2019-2021)
Table 18. Global Onychomycosis (Tinea Unguium) Drug Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Onychomycosis (Tinea Unguium) Drug Producing Area Distribution and Sales Area
Table 20. Players Onychomycosis (Tinea Unguium) Drug Products Offered
Table 21. Onychomycosis (Tinea Unguium) Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Onychomycosis (Tinea Unguium) Drug Sales by Region (2016-2021) (K Units)
Table 25. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region (2016-2021)
Table 26. Global Onychomycosis (Tinea Unguium) Drug Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Region (2016-2021)
Table 28. Americas Onychomycosis (Tinea Unguium) Drug Sales by Country (2016-2021) & (K Units)
Table 29. Americas Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country (2016-2021)
Table 30. Americas Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Country (2016-2021)
Table 32. Americas Onychomycosis (Tinea Unguium) Drug Sales by Type (2016-2021) & (K Units)
Table 33. Americas Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2016-2021)
Table 34. Americas Onychomycosis (Tinea Unguium) Drug Sales by Application (2016-2021) & (K Units)
Table 35. Americas Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2016-2021)
Table 36. APAC Onychomycosis (Tinea Unguium) Drug Sales by Region (2016-2021) & (K Units)
Table 37. APAC Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region (2016-2021)
Table 38. APAC Onychomycosis (Tinea Unguium) Drug Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Region (2016-2021)
Table 40. APAC Onychomycosis (Tinea Unguium) Drug Sales by Type (2016-2021) & (K Units)
Table 41. APAC Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2016-2021)
Table 42. APAC Onychomycosis (Tinea Unguium) Drug Sales by Application (2016-2021) & (K Units)
Table 43. APAC Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2016-2021)
Table 44. Europe Onychomycosis (Tinea Unguium) Drug Sales by Country (2016-2021) & (K Units)
Table 45. Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country (2016-2021)
Table 46. Europe Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Country (2016-2021)
Table 48. Europe Onychomycosis (Tinea Unguium) Drug Sales by Type (2016-2021) & (K Units)
Table 49. Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2016-2021)
Table 50. Europe Onychomycosis (Tinea Unguium) Drug Sales by Application (2016-2021) & (K Units)
Table 51. Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales by Application (2016-2021) & (K Units)
Table 59. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Onychomycosis (Tinea Unguium) Drug
Table 61. Key Application and Potential Industries of Onychomycosis (Tinea Unguium) Drug
Table 62. Key Challenges of Onychomycosis (Tinea Unguium) Drug
Table 63. Key Trends of Onychomycosis (Tinea Unguium) Drug
Table 64. Onychomycosis (Tinea Unguium) Drug Distributors List
Table 65. Onychomycosis (Tinea Unguium) Drug Customer List
Table 66. Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Region (2021-2026) & (K Units)
Table 67. Global Onychomycosis (Tinea Unguium) Drug Consumption Market Forecast by Region
Table 68. Global Onychomycosis (Tinea Unguium) Drug Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Onychomycosis (Tinea Unguium) Drug Sales Forecast by Country (2021-2026) & (K Units)
Table 71. Americas Onychomycosis (Tinea Unguium) Drug Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Onychomycosis (Tinea Unguium) Drug Sales Forecast by Region (2021-2026) & (K Units)
Table 73. APAC Onychomycosis (Tinea Unguium) Drug Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Onychomycosis (Tinea Unguium) Drug Sales Forecast by Country (2021-2026) & (K Units)
Table 75. Europe Onychomycosis (Tinea Unguium) Drug Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Type (2021-2026) & (K Units)
Table 79. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Onychomycosis (Tinea Unguium) Drug Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Application (2021-2026) & (K Units)
Table 83. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Onychomycosis (Tinea Unguium) Drug Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share Forecast by Application (2021-2026)
Table 86. Johnson and Johnson Basic Information, Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
Table 87. Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Product Offered
Table 88. Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 89. Johnson and Johnson Main Business
Table 90. Johnson and Johnson Latest Developments
Table 91. GSK Basic Information, Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
Table 92. GSK Onychomycosis (Tinea Unguium) Drug Product Offered
Table 93. GSK Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 94. GSK Main Business
Table 95. GSK Latest Developments
Table 96. Novartis Basic Information, Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
Table 97. Novartis Onychomycosis (Tinea Unguium) Drug Product Offered
Table 98. Novartis Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 99. Novartis Main Business
Table 100. Novartis Latest Developments
Table 101. Pfizer Basic Information, Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
Table 102. Pfizer Onychomycosis (Tinea Unguium) Drug Product Offered
Table 103. Pfizer Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 104. Pfizer Main Business
Table 105. Pfizer Latest Developments
Table 106. Valeant Pharma Basic Information, Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product Offered
Table 108. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 109. Valeant Pharma Main Business
Table 110. Valeant Pharma Latest Developments
Table 111. Kaken Pharmaceutical Basic Information, Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
Table 112. Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Offered
Table 113. Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 114. Kaken Pharmaceutical Main Business
Table 115. Kaken Pharmaceutical Latest Developments
Table 116. Galderma Basic Information, Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
Table 117. Galderma Onychomycosis (Tinea Unguium) Drug Product Offered
Table 118. Galderma Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 119. Galderma Main Business
Table 120. Galderma Latest Developments
Table 121. Xiuzheng Pharmaceutical Basic Information, Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
Table 122. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Offered
Table 123. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 124. Xiuzheng Pharmaceutical Main Business
Table 125. Xiuzheng Pharmaceutical Latest Developments
Table 126. Letai Basic Information, Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
Table 127. Letai Onychomycosis (Tinea Unguium) Drug Product Offered
Table 128. Letai Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 129. Letai Main Business
Table 130. Letai Latest Developments
Table 131. Qilu Pharmaceutical Basic Information, Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
Table 132. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Offered
Table 133. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 134. Qilu Pharmaceutical Main Business
Table 135. Qilu Pharmaceutical Latest Developments
Table 1. Onychomycosis (Tinea Unguium) Drug Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Oral Medication
Table 3. Major Players of External Medicine
Table 4. Global Onychomycosis (Tinea Unguium) Drug Sales by Type (2016-2021) & (K Units)
Table 5. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2016-2021)
Table 6. Global Onychomycosis (Tinea Unguium) Drug Revenue by Type (2016-2021) & ($ million)
Table 7. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Type (2016-2021)
Table 8. Global Onychomycosis (Tinea Unguium) Drug Sale Price by Type (2016-2021)
Table 9. Global Onychomycosis (Tinea Unguium) Drug Sales by Application (2016-2021) & (K Units)
Table 10. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2016-2021)
Table 11. Global Onychomycosis (Tinea Unguium) Drug Value by Application (2016-2021)
Table 12. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Application (2016-2021)
Table 13. Global Onychomycosis (Tinea Unguium) Drug Sale Price by Application (2016-2021)
Table 14. Global Onychomycosis (Tinea Unguium) Drug Sales by Company (2019-2021) & (K Units)
Table 15. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Company (2019-2021)
Table 16. Global Onychomycosis (Tinea Unguium) Drug Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Company (2019-2021)
Table 18. Global Onychomycosis (Tinea Unguium) Drug Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Onychomycosis (Tinea Unguium) Drug Producing Area Distribution and Sales Area
Table 20. Players Onychomycosis (Tinea Unguium) Drug Products Offered
Table 21. Onychomycosis (Tinea Unguium) Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Onychomycosis (Tinea Unguium) Drug Sales by Region (2016-2021) (K Units)
Table 25. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region (2016-2021)
Table 26. Global Onychomycosis (Tinea Unguium) Drug Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Region (2016-2021)
Table 28. Americas Onychomycosis (Tinea Unguium) Drug Sales by Country (2016-2021) & (K Units)
Table 29. Americas Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country (2016-2021)
Table 30. Americas Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Country (2016-2021)
Table 32. Americas Onychomycosis (Tinea Unguium) Drug Sales by Type (2016-2021) & (K Units)
Table 33. Americas Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2016-2021)
Table 34. Americas Onychomycosis (Tinea Unguium) Drug Sales by Application (2016-2021) & (K Units)
Table 35. Americas Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2016-2021)
Table 36. APAC Onychomycosis (Tinea Unguium) Drug Sales by Region (2016-2021) & (K Units)
Table 37. APAC Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region (2016-2021)
Table 38. APAC Onychomycosis (Tinea Unguium) Drug Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Region (2016-2021)
Table 40. APAC Onychomycosis (Tinea Unguium) Drug Sales by Type (2016-2021) & (K Units)
Table 41. APAC Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2016-2021)
Table 42. APAC Onychomycosis (Tinea Unguium) Drug Sales by Application (2016-2021) & (K Units)
Table 43. APAC Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2016-2021)
Table 44. Europe Onychomycosis (Tinea Unguium) Drug Sales by Country (2016-2021) & (K Units)
Table 45. Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country (2016-2021)
Table 46. Europe Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Country (2016-2021)
Table 48. Europe Onychomycosis (Tinea Unguium) Drug Sales by Type (2016-2021) & (K Units)
Table 49. Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2016-2021)
Table 50. Europe Onychomycosis (Tinea Unguium) Drug Sales by Application (2016-2021) & (K Units)
Table 51. Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales by Application (2016-2021) & (K Units)
Table 59. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Onychomycosis (Tinea Unguium) Drug
Table 61. Key Application and Potential Industries of Onychomycosis (Tinea Unguium) Drug
Table 62. Key Challenges of Onychomycosis (Tinea Unguium) Drug
Table 63. Key Trends of Onychomycosis (Tinea Unguium) Drug
Table 64. Onychomycosis (Tinea Unguium) Drug Distributors List
Table 65. Onychomycosis (Tinea Unguium) Drug Customer List
Table 66. Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Region (2021-2026) & (K Units)
Table 67. Global Onychomycosis (Tinea Unguium) Drug Consumption Market Forecast by Region
Table 68. Global Onychomycosis (Tinea Unguium) Drug Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Onychomycosis (Tinea Unguium) Drug Sales Forecast by Country (2021-2026) & (K Units)
Table 71. Americas Onychomycosis (Tinea Unguium) Drug Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Onychomycosis (Tinea Unguium) Drug Sales Forecast by Region (2021-2026) & (K Units)
Table 73. APAC Onychomycosis (Tinea Unguium) Drug Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Onychomycosis (Tinea Unguium) Drug Sales Forecast by Country (2021-2026) & (K Units)
Table 75. Europe Onychomycosis (Tinea Unguium) Drug Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Type (2021-2026) & (K Units)
Table 79. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Onychomycosis (Tinea Unguium) Drug Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Application (2021-2026) & (K Units)
Table 83. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Onychomycosis (Tinea Unguium) Drug Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share Forecast by Application (2021-2026)
Table 86. Johnson and Johnson Basic Information, Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
Table 87. Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Product Offered
Table 88. Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 89. Johnson and Johnson Main Business
Table 90. Johnson and Johnson Latest Developments
Table 91. GSK Basic Information, Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
Table 92. GSK Onychomycosis (Tinea Unguium) Drug Product Offered
Table 93. GSK Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 94. GSK Main Business
Table 95. GSK Latest Developments
Table 96. Novartis Basic Information, Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
Table 97. Novartis Onychomycosis (Tinea Unguium) Drug Product Offered
Table 98. Novartis Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 99. Novartis Main Business
Table 100. Novartis Latest Developments
Table 101. Pfizer Basic Information, Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
Table 102. Pfizer Onychomycosis (Tinea Unguium) Drug Product Offered
Table 103. Pfizer Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 104. Pfizer Main Business
Table 105. Pfizer Latest Developments
Table 106. Valeant Pharma Basic Information, Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product Offered
Table 108. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 109. Valeant Pharma Main Business
Table 110. Valeant Pharma Latest Developments
Table 111. Kaken Pharmaceutical Basic Information, Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
Table 112. Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Offered
Table 113. Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 114. Kaken Pharmaceutical Main Business
Table 115. Kaken Pharmaceutical Latest Developments
Table 116. Galderma Basic Information, Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
Table 117. Galderma Onychomycosis (Tinea Unguium) Drug Product Offered
Table 118. Galderma Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 119. Galderma Main Business
Table 120. Galderma Latest Developments
Table 121. Xiuzheng Pharmaceutical Basic Information, Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
Table 122. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Offered
Table 123. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 124. Xiuzheng Pharmaceutical Main Business
Table 125. Xiuzheng Pharmaceutical Latest Developments
Table 126. Letai Basic Information, Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
Table 127. Letai Onychomycosis (Tinea Unguium) Drug Product Offered
Table 128. Letai Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 129. Letai Main Business
Table 130. Letai Latest Developments
Table 131. Qilu Pharmaceutical Basic Information, Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
Table 132. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Offered
Table 133. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 134. Qilu Pharmaceutical Main Business
Table 135. Qilu Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Onychomycosis (Tinea Unguium) Drug
Figure 2. Onychomycosis (Tinea Unguium) Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Onychomycosis (Tinea Unguium) Drug Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Onychomycosis (Tinea Unguium) Drug Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Onychomycosis (Tinea Unguium) Drug Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Oral Medication
Figure 10. Product Picture of External Medicine
Figure 11. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type in 2020
Figure 12. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Type (2016-2021)
Figure 13. Onychomycosis (Tinea Unguium) Drug Consumed in Age under 18
Figure 14. Global Onychomycosis (Tinea Unguium) Drug Market: Age under 18 (2016-2021) & (K Units)
Figure 15. Onychomycosis (Tinea Unguium) Drug Consumed in Age 18-50
Figure 16. Global Onychomycosis (Tinea Unguium) Drug Market: Age 18-50 (2016-2021) & (K Units)
Figure 17. Onychomycosis (Tinea Unguium) Drug Consumed in Age above 50
Figure 18. Global Onychomycosis (Tinea Unguium) Drug Market: Age above 50 (2016-2021) & (K Units)
Figure 19. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2016-2021)
Figure 20. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Application in 2020
Figure 21. Onychomycosis (Tinea Unguium) Drug Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Company in 2020
Figure 23. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Regions (2016-2021)
Figure 24. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Region in 2020
Figure 25. Americas Onychomycosis (Tinea Unguium) Drug Sales 2016-2021 (K Units)
Figure 26. Americas Onychomycosis (Tinea Unguium) Drug Revenue 2016-2021 ($ Millions)
Figure 27. APAC Onychomycosis (Tinea Unguium) Drug Sales 2016-2021 (K Units)
Figure 28. APAC Onychomycosis (Tinea Unguium) Drug Revenue 2016-2021 ($ Millions)
Figure 29. Europe Onychomycosis (Tinea Unguium) Drug Sales 2016-2021 (K Units)
Figure 30. Europe Onychomycosis (Tinea Unguium) Drug Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales 2016-2021 (K Units)
Figure 32. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Revenue 2016-2021 ($ Millions)
Figure 33. Americas Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country in 2020
Figure 34. Americas Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Country in 2020
Figure 35. Americas Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type in 2020
Figure 36. Americas Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application in 2020
Figure 37. United States Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region in 2020
Figure 42. APAC Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Regions in 2020
Figure 43. APAC Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type in 2020
Figure 44. APAC Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application in 2020
Figure 45. China Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country in 2020
Figure 52. Europe Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Country in 2020
Figure 53. Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type in 2020
Figure 54. Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application in 2020
Figure 55. Germany Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application in 2020
Figure 64. Egypt Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Figure 1. Picture of Onychomycosis (Tinea Unguium) Drug
Figure 2. Onychomycosis (Tinea Unguium) Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Onychomycosis (Tinea Unguium) Drug Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Onychomycosis (Tinea Unguium) Drug Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Onychomycosis (Tinea Unguium) Drug Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Oral Medication
Figure 10. Product Picture of External Medicine
Figure 11. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type in 2020
Figure 12. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Type (2016-2021)
Figure 13. Onychomycosis (Tinea Unguium) Drug Consumed in Age under 18
Figure 14. Global Onychomycosis (Tinea Unguium) Drug Market: Age under 18 (2016-2021) & (K Units)
Figure 15. Onychomycosis (Tinea Unguium) Drug Consumed in Age 18-50
Figure 16. Global Onychomycosis (Tinea Unguium) Drug Market: Age 18-50 (2016-2021) & (K Units)
Figure 17. Onychomycosis (Tinea Unguium) Drug Consumed in Age above 50
Figure 18. Global Onychomycosis (Tinea Unguium) Drug Market: Age above 50 (2016-2021) & (K Units)
Figure 19. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2016-2021)
Figure 20. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Application in 2020
Figure 21. Onychomycosis (Tinea Unguium) Drug Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Company in 2020
Figure 23. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Regions (2016-2021)
Figure 24. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Region in 2020
Figure 25. Americas Onychomycosis (Tinea Unguium) Drug Sales 2016-2021 (K Units)
Figure 26. Americas Onychomycosis (Tinea Unguium) Drug Revenue 2016-2021 ($ Millions)
Figure 27. APAC Onychomycosis (Tinea Unguium) Drug Sales 2016-2021 (K Units)
Figure 28. APAC Onychomycosis (Tinea Unguium) Drug Revenue 2016-2021 ($ Millions)
Figure 29. Europe Onychomycosis (Tinea Unguium) Drug Sales 2016-2021 (K Units)
Figure 30. Europe Onychomycosis (Tinea Unguium) Drug Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales 2016-2021 (K Units)
Figure 32. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Revenue 2016-2021 ($ Millions)
Figure 33. Americas Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country in 2020
Figure 34. Americas Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Country in 2020
Figure 35. Americas Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type in 2020
Figure 36. Americas Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application in 2020
Figure 37. United States Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region in 2020
Figure 42. APAC Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Regions in 2020
Figure 43. APAC Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type in 2020
Figure 44. APAC Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application in 2020
Figure 45. China Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country in 2020
Figure 52. Europe Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Country in 2020
Figure 53. Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type in 2020
Figure 54. Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application in 2020
Figure 55. Germany Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application in 2020
Figure 64. Egypt Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Onychomycosis (Tinea Unguium) Drug Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
